Understanding Hodgkin Lymphoma

Is Cancer Risk Higher for the Ashkenazi Jewish Population?

Is the Ashkenazi Jewish population at a higher risk for certain types of cancers? Dr. Angela Bradbury explains.


Cancer & Genetics: Are Families Always at Risk?

Is all cancer hereditary? What increases my risk and the risk of my family? Dr. Angela Bradbury from Perelman School of Medicine at the University of Pennsylvania shares her expert opinion.


Expert Perspective: Understanding Precision Medicine

From the 2017 ASCO Survivorship Symposium, Dr. Angela Bradbury joined Patient Power to help viewers to explain the role precision medicine in cancer treatment today.


Making Sense of Precision Medicine Test Results

Learn more about personalized medicine, also known as precision medicine, in this web interview with Patient Power Host Andrew Schorr and Dr. Razelle Kurzrock, Director of the Center for Personalized Cancer Therapy at UC San Diego.


The Goals of Survivorship and Promises of Precision Medicine

In this replay from the 2017 ASCO survivorship meeting in San Diego, Patient Power catches up with Director of Oncology, Treasa McPherson, of UC Davis Comprehensive Cancer Center.


Patient, Care Partner and Researcher Helps Other Patients Navigate Cancer Diagnosis

From the 2017 ASCO survivorship symposium in San Diego, Patient Power catches up with Treasa McPherson, Director of Oncology of UC Davis Comprehensive Cancer Center.


The Impact of Genetic Testing: How Does It Affect Your Future?

A pediatric oncologist shares her perspective on the role of genetic testing related to early intervention and cancer treatment.


Collaboration Among Medical Centers to Deliver Optimal Care for Rare Cancers: What Patients Should Know

Dr. Michael Grunwald from Carolinas HealthCare System's Levine Cancer Institute discusses how he works with patients living with rare cancers to ensure they receive optimal care.


Big Pharma Joins the Patient Engagement Conversation

Andrew reports live from the annual Eyeforpharma meeting in Barcelona, Spain as big pharma gathers to discuss their role in patient engagement.


Showing 9 of 33 programs

Page last updated on November 7, 2013